The potential role of clinical pharmacy services in patients with cardiovascular diseases
Clinical pharmacy is deemed an integral component of a health care system. The presence of clinical pharmacists in medical rounds could assist physicians in optimizing patients' pharmacotherapy. Moreover, clinical pharmacists may reduce adverse effects and medication errors insofar as they contribute significantly to the detection and management of drug-related problems, not least in patients with cardiovascular diseases, who have the highest rank in the frequency of medication errors. Clinical pharmacists can also collaborate with physicians in the management of cardiovascular risk factors as well as anticoagulation therapy based on patients' specific situations.In summary, the practice of clinical pharmacy is considered a crucial part of a health care team to improve the level of patients' care by increasing the quality of therapy with the least expense for a health care system.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
The journal of Tehran Heart Center - 7(2012), 2 vom: 11., Seite 41-6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Talasaz, Azita Hajhossein [VerfasserIn] |
---|
Themen: |
Cardiovascular diseases |
---|
Anmerkungen: |
Date Completed 18.10.2012 Date Revised 21.10.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM221895248 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM221895248 | ||
003 | DE-627 | ||
005 | 20231224052952.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2012 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0739.xml |
035 | |a (DE-627)NLM221895248 | ||
035 | |a (NLM)23074636 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Talasaz, Azita Hajhossein |e verfasserin |4 aut | |
245 | 1 | 4 | |a The potential role of clinical pharmacy services in patients with cardiovascular diseases |
264 | 1 | |c 2012 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.10.2012 | ||
500 | |a Date Revised 21.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Clinical pharmacy is deemed an integral component of a health care system. The presence of clinical pharmacists in medical rounds could assist physicians in optimizing patients' pharmacotherapy. Moreover, clinical pharmacists may reduce adverse effects and medication errors insofar as they contribute significantly to the detection and management of drug-related problems, not least in patients with cardiovascular diseases, who have the highest rank in the frequency of medication errors. Clinical pharmacists can also collaborate with physicians in the management of cardiovascular risk factors as well as anticoagulation therapy based on patients' specific situations.In summary, the practice of clinical pharmacy is considered a crucial part of a health care team to improve the level of patients' care by increasing the quality of therapy with the least expense for a health care system | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cardiovascular diseases | |
650 | 4 | |a Patient care team | |
650 | 4 | |a Pharmacy | |
650 | 4 | |a Professional role | |
773 | 0 | 8 | |i Enthalten in |t The journal of Tehran Heart Center |d 2010 |g 7(2012), 2 vom: 11., Seite 41-6 |w (DE-627)NLM221892508 |x 1735-5370 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2012 |g number:2 |g day:11 |g pages:41-6 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2012 |e 2 |b 11 |h 41-6 |